Analys

Alligator Bioscience (Q3 Review): Rights Issue of up to SEK120m - Redeye

{newsItem.title}

Redeye Publicerad: 24 Oct 07:12

Alligator Bioscience

Redeye reviews Alligator Bioscience’s Q3 report 2025. The main event is the rights issue of SEK120m announced on Wednesday evening. The main positive event was the extensive investigator-sponsored study in bile duct cancer in France.

Länk till analysen i sin helhet: https://www.redeye.se/research/1131505/alligator-bioscience-q3-review-rights-issue-of-up-to-sek120m?utm_source=finwire&utm_medium=RSS

Nyheter om Alligator Bioscience

Läses av andra just nu

Om aktien Alligator Bioscience

Senaste nytt